The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
Open Access
Abstract
A possible link between diet and cancer has long been considered, with growing interest in phytochemicals. Soy isoflavones have been associated with a reduced risk of prostate cancer in Asian populations. Of the soy isoflavones, genistein and daidzein, in particular, have been studied, but recently, equol as a derivative has gained interest because it is more biologically potent. Different mechanisms of action have already been studied for the different isoflavones in multiple conditions, such as breast, gastrointestinal, and urogenital cancers. Many of these mechanisms of action could also be demonstrated in the prostate, both in vitro and in vivo. This review focuses on the known mechanisms of action at the cellular level and compares them between genistein, daidzein, and equol. These include androgen- and estrogen-mediated pathways, regulation of the cell cycle and cell proliferation, apoptosis, angiogenesis, and metastasis. In addition, antioxidant and anti-inflammatory effects and epigenetics are addressed.Keywords
This publication has 138 references indexed in Scilit:
- Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate CancerPLOS ONE, 2013
- The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growthMolecular Cancer, 2012
- Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and FeedbacksMolecular and Cellular Biology, 2012
- Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancerJournal of Molecular Signaling, 2010
- The Biochemistry, Chemistry and Physiology of the Isoflavones in Soybeans and their Food ProductsLymphatic Research and Biology, 2010
- Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag ratsThe Prostate, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Identification of a Biphasic Role for Genistein in the Regulation of Prostate Cancer Growth and MetastasisCancer Research, 2009
- Regulation of Akt/FOXO3a/GSK-3β/AR Signaling Network by Isoflavone in Prostate Cancer CellsJournal of Biological Chemistry, 2008
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004